Literature DB >> 21952809

Monocytes link atherosclerosis and cancer.

Mikael J Pittet1, Filip K Swirski.   

Abstract

From many perspectives, cardiovascular diseases and cancers are fundamentally different. On the one hand, atherosclerosis is a disease of lipid accumulation driven by diet and lifestyle, whereas cancer is an attack "from within" driven by mutations. Nevertheless, studies over the past 20 years have forced us to re-evaluate such a view. We are learning that, among other factors, the immune system is indispensable for the development and progression of both diseases. Its components are not only reactive but can also orchestrate both tumor and atherosclerotic lesion growth. In this Viewpoint, we explore how monocytes, which are key constituents of the immune system, forge links between cardiovascular diseases and cancers.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2011        PMID: 21952809      PMCID: PMC3817567          DOI: 10.1002/eji.201141727

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  43 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 4.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

Review 5.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.

Authors:  Christophe Combadière; Stéphane Potteaux; Mathieu Rodero; Tabassome Simon; Adeline Pezard; Bruno Esposito; Régine Merval; Amanda Proudfoot; Alain Tedgui; Ziad Mallat
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

8.  Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.

Authors:  Harmon Eyre; Richard Kahn; Rose Marie Robertson; Nathaniel G Clark; Colleen Doyle; Yuling Hong; Ted Gansler; Thomas Glynn; Robert A Smith; Kathryn Taubert; Michael J Thun
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  15 in total

1.  Modulating Macrophage Polarization through CCR2 Inhibition and Multivalent Engagement.

Authors:  Michael B Deci; Scott W Ferguson; Sydney L Scatigno; Juliane Nguyen
Journal:  Mol Pharm       Date:  2018-06-04       Impact factor: 4.939

Review 2.  Applying nanomedicine in maladaptive inflammation and angiogenesis.

Authors:  Amr Alaarg; Carlos Pérez-Medina; Josbert M Metselaar; Matthias Nahrendorf; Zahi A Fayad; Gert Storm; Willem J M Mulder
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 15.470

3.  A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.

Authors:  Cyril J Craven
Journal:  Theor Biol Med Model       Date:  2014-09-14       Impact factor: 2.432

Review 4.  The journey from stem cell to macrophage.

Authors:  Mikael J Pittet; Matthias Nahrendorf; Filip K Swirski
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

5.  Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.

Authors:  Zhenquan Jia; Palanisamy Nallasamy; Dongmin Liu; Halley Shah; Jason Z Li; Rojin Chitrakar; Hongwei Si; John McCormick; Hong Zhu; Wei Zhen; Yunbo Li
Journal:  J Nutr Biochem       Date:  2014-12-15       Impact factor: 6.048

6.  Visualization of bone marrow monocyte mobilization using Cx3cr1gfp/+Flt3L-/- reporter mouse by multiphoton intravital microscopy.

Authors:  Maximilien Evrard; Shu Zhen Chong; Sapna Devi; Weng Keong Chew; Bernett Lee; Michael Poidinger; Florent Ginhoux; Suet Mien Tan; Lai Guan Ng
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

7.  Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism.

Authors:  Pon V Anandh Babu; Hongwei Si; Dongmin Liu
Journal:  Mol Nutr Food Res       Date:  2012-07-02       Impact factor: 5.914

8.  Genistein inhibits TNF-α-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice.

Authors:  Zhenquan Jia; Pon Velayutham Anandh Babu; Hongwei Si; Palanisamy Nallasamy; Hong Zhu; Wei Zhen; Hara P Misra; Yunbo Li; Dongmin Liu
Journal:  Int J Cardiol       Date:  2013-04-12       Impact factor: 4.164

9.  TLR9-mediated inflammation drives a Ccr2-independent peripheral monocytosis through enhanced extramedullary monocytopoiesis.

Authors:  Lehn K Weaver; Niansheng Chu; Edward M Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

Review 10.  Nanotherapeutic Shots through the Heart of Plaque.

Authors:  Yogendra Kanthi; Adam de la Zerda; Bryan Ronain Smith
Journal:  ACS Nano       Date:  2020-01-27       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.